Abstract
Electronic processes and communication technologies are more and more often employed to provide healthcare services to caregivers and their patients. Such solutions are currently referred as e-health, the most popular and widely distributed being those based on telemedicine and mobile health (m-health). A specific application of telemedicine for hypertension management is blood pressure telemonitoring (BPT), which allows remote data transmission of BP and additional information on patients’ health status from their living site or from a community setting to the doctor’s office or the hospital. Several randomized studies have documented a significant BP reduction with regular BPT compared to usual care, particularly in high risk hypertensive patients. Additional benefits are observed when BPT is offered under the supervision of a team of healthcare professionals, including a community pharmacist. BPT may also be provided in the context of m-health solutions, which commonly include wireless diagnostic and clinical decision support tools. M-health has the potential to promote patient’s self-management, as a complement to the doctor’s intervention, and encourage greater participation in medical decision making. Current statistics show that half of smartphone owners gather health information through their phone and 19 % use a health app. In case of hypertensive patients the most popular apps are those with tracking function, including BPT. Thus, e-health, and in particular BPT and m-health, are progressively gaining a key role in the management of hypertensive patients, having the potential to improve the quality of the delivered care and to more effectively prevent cardiovascular consequences of high BP.
Similar content being viewed by others
References
Moghaddasi H, Asadi F, Hosseini A, Ebnehoseini Z. E-health: a global approach with extensive semantic variation. J Med Syst. 2012;36:3173–6.
Sood S, Mbarika V, Jugoo S, Dookhy R, Doarn CR, Prakash N, Merrell RC. What is telemedicine? A collection of 104 peer-reviewed perspectives and theoretical underpinnings. Telemed J E Health. 2007;13:573–90.
Silva BM, Rodrigues JJ, de la Torre Díez I, López-Coronado M, Saleem K. Mobile-health: a review of current state in 2015. J Biomed Inform. 2015;56:265–72.
Omboni S, Ferrari R. The role of telemedicine in hypertension management: focus on blood pressure telemonitoring. Curr Hypertens Rep. 2015;17:535.
Purcell R, McInnes S, Halcomb EJ. Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviews. BMC Fam Pract. 2014;15:34.
Parati G, Omboni S. Role of home blood pressure telemonitoring in hypertension management: an update. Blood Press Monit. 2010;15:285–95.
Paré G, Mogadem K, Pineau G, St-Hilaire C. Clinical effects of home telemonitoring in the context of diabetes, asthma, heart failure and hypertension: a systematic review. J Med Internet Res. 2010;12:e21.
Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens. 2011;24:989–98.
Verberk WJ, Kessels AG, Thien T. Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis. Blood Press Monit. 2011;16:149–55.
AbuDagga A, Resnick HE, Alwan M. Impact of blood pressure telemonitoring on hypertension outcomes: a literature review. Telemed J E Health. 2010;16:830–8.
Zullig LL, Melnyk SD, Goldstein K, Shaw RJ, Bosworth HB. The role of home blood pressure telemonitoring in managing hypertensive populations. Curr Hypertens Rep. 2013;15:346–55.
Liu S, Dunford SD, Leung YW, Brooks D, Thomas SG, Eysenbach G, Nolan RP. Reducing blood pressure with Internet-based interventions: a meta-analysis. Can J Cardiol. 2013;29:613–21.
Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31:455–68.
Mc Kinstry B, Hanley J, Lewis S. Telemonitoring in the management of high blood pressure. Curr Pharm Des. 2015;21:823–7.
Carter BL, Bosworth HB, Green BB. The hypertension team: the role of the pharmacist, nurse and teamwork in hypertension therapy. J Clin Hypertens. 2012;14:51–65.
Omboni S, Sala E. The pharmacist and the management of arterial hypertension: the role of blood pressure monitoring and telemonitoring. Expert Rev Cardiovasc Ther. 2015;13:209–21.
Green BB, Ralston JD, Fishman PA, Catz SL, Cook A, Carlson J, Tyll L, Carrell D, Thompson RS. Electronic communications and home blood pressure monitoring (e-BP) study: design, delivery, and evaluation framework. Contemp Clin Trials. 2008;29:376–95.
Green BB, Cook AJ, Ralston JD, et al. Effectiveness of home blood pressure monitoring, web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA. 2008;299:2857–67.
Green BB, Anderson ML, Ralston JD, et al. Blood pressure 1 year after completion of web-based pharmacist care. JAMA Intern Med. 2013;173:1250–2.
Fishman PA, Cook AJ, Anderson ML, Ralston JD, Catz SL, Carrell D, Carlson J, Green BB. Improving BP control through electronic communications: an economic evaluation. Am J Manag Care. 2013;19:709–16.
Robins LS, Jackson JE, Green BB, Korngiebel D, Force RW, Baldwin LM. Barriers and facilitators to evidence-based blood pressure control in community practice. J Am Board Fam Med. 2013;26:539–57.
Ralston JD, Cook AJ, Anderson ML, Catz SL, Fishman PA, Carlson J, Johnson R, Green BB. Home blood pressure monitoring, secure electronic messaging and medication intensification for improving hypertension control: a mediation analysis. Appl Clin Inform. 2014;5:232–48.
Margolis KL, Kerby TJ, Asche SE, Bergdall AR, Maciosek MV, O’Connor PJ, Sperl-Hillen JM. Design and rationale for Home Blood Pressure Telemonitoring and Case Management to Control Hypertension (HyperLink): a cluster randomized trial. Contemp Clin Trials. 2012;33:794–803.
Margolis KL, Asche SE, Bergdall AR, et al. Effect of home blood pressure telemonitoring and pharmacist management on blood pressure control: a cluster randomized clinical trial. JAMA. 2013;310:46–56.
Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Maciosek MV, Nyboer RA, O’Connor PJ, Pawloski PA, Sperl-Hillen JM, Trower NK, Tucker AD, Green BB. A successful multifaceted trial to improve hypertension control in primary care: why did it work? J Gen Intern Med. 2015;30:1665–72.
Kerby TJ, Asche SE, Maciosek MV, et al. Adherence to blood pressure telemonitoring in a cluster-randomized clinical trial. J Clin Hypertens. 2012;14:668–74.
Magid DJ, Olson KL, Billups SJ, Wagner NM, Lyons EE, Kroner BA. A pharmacist-led, American Heart Association Heart360 Web-enabled home blood pressure monitoring program. Circ Cardiovasc Qual Outcomes. 2013;6:157–63.
Magid DJ, Ho PM, Olson KL, et al. A multimodal blood pressure control intervention in 3 healthcare systems. Am J Manag Care. 2011;17:e96–103.
James K, Dolan E, O’Brien E. Making ambulatory blood pressure monitoring accessible in pharmacies. Blood Press Monit. 2014;19:134–9.
Omboni S, Caserini M. Telemonitoring of 24-h blood pressure in local pharmacies and blood pressure control in the community: results from the TEMPLAR project. J Hypertens. 2014;32(e-Supplement 1):e13 [abstract].
GSMA. The Mobile Economy 2015. http://gsmamobileeconomy.com/global/GSMA_Global_Mobile_Economy_Report_2015.pdf. Accessed 2 Feb 2016.
Kumar S, Nilsen WJ, Abernethy A, Atienza A, Patrick K, Pavel M, Riley WT, Shar A, Spring B, Spruijt-Metz D, Hedeker D, Honavar V, Kravitz R, Lefebvre RC, Mohr DC, Murphy SA, Quinn C, Shusterman V, Swendeman D. Mobile health technology evaluation: the mHealth evidence workshop. Am J Prev Med. 2013;45:228–36.
Kumar N, Khunger M, Gupta A, Garg N. A content analysis of smartphone-based applications for hypertension management. J Am Soc Hypertens. 2015;9:130–6.
Green BB. BP here, there, and everywhere–mobile health applications (apps) and hypertension care. J Am Soc Hypertens. 2015;9:137–9.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosure
SO received consultancy fees from Biotechmed Ltd., provider of telemedicine services, and from Microlife, manufacturer of blood pressure measuring devices. None of the other authors has any conflict of interest to declare.
Conflict of interest
None.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Rights and permissions
About this article
Cite this article
Omboni, S., Caserini, M. & Coronetti, C. Telemedicine and M-Health in Hypertension Management: Technologies, Applications and Clinical Evidence. High Blood Press Cardiovasc Prev 23, 187–196 (2016). https://doi.org/10.1007/s40292-016-0143-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40292-016-0143-6